A total of 579 metastatic breast cancer patients with available HER2 statuses from our NGS database were analyzed, including 495 patients with metastasis following radical operation and 84 patients with de novo stage IV breast cancer (Additional file 7: Fig. S1). Here, ERBB2 is linked to breast carcinoma.